CM
COGT icon

Caption Management’s Cogent Biosciences COGT Stock Holding History

Caption Management’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.92M Buy
50,000
+39,500
+376% +$1.46M 0.01% 831
2025
Q4 		$373K Sell
10,500
-369,500
-97% -$10.4M ﹤0.01% 1290
2025
Q3 		$5.46M Sell
380,000
-928,600
-71% -$11M 0.04% 463
2025
Q2 		$9.4M Buy
+1,308,600
New +$7.25M 0.1% 223
2024
Q2 		– Sell
-39,800
Closed -$267K – 1208
2024
Q1 		$267K Buy
+39,800
New +$246K ﹤0.01% 965

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Caption Management's COGT Position: Q1 2026 in Review

Caption Management opened a new position in Cogent Biosciences (COGT) in Q1 2026: 20,000 shares worth $770K. The stake represents ﹤0.01% of the portfolio and ranks #1096 among its holdings. This is a return to the name: Caption Management previously reported a position in COGT as recently as Q3 2025.

Caption Management first reported a position in COGT in Q2 2022 and has held it in 6 quarters since. The position peaked at $3.14M in Q2 2025. 305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.

  • Caption Management held 20,000 shares of Cogent Biosciences worth $770K as of Q1 2026.
  • Cogent Biosciences was a new Caption Management position in Q1 2026.
  • Cogent Biosciences made up ﹤0.01% of Caption Management's portfolio in Q1 2026, its #1096 holding.
  • Caption Management first reported a position in Cogent Biosciences in Q2 2022 and has held it in 6 quarters since.
  • Caption Management's Cogent Biosciences position peaked at $3.14M in Q2 2025.
  • 305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.